摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(2-{4-[2,4-dioxo(1,3-thiazolidin-5-yl)methyl]phenoxy}ethyl)-N-methyl-6,8-disulfanyloctamide | 292615-81-7

中文名称
——
中文别名
——
英文名称
N-(2-{4-[2,4-dioxo(1,3-thiazolidin-5-yl)methyl]phenoxy}ethyl)-N-methyl-6,8-disulfanyloctamide
英文别名
N-[2-[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]ethyl]-N-methyl-6,8-bis(sulfanyl)octanamide
N-(2-{4-[2,4-dioxo(1,3-thiazolidin-5-yl)methyl]phenoxy}ethyl)-N-methyl-6,8-disulfanyloctamide化学式
CAS
292615-81-7
化学式
C21H30N2O4S3
mdl
——
分子量
470.678
InChiKey
ALOQRLGFDCPDSP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    30
  • 可旋转键数:
    13
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    103
  • 氢给体数:
    3
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 1,2-dithiolane derivatives
    申请人:University of Mississippi
    公开号:US06353011B1
    公开(公告)日:2002-03-05
    This invention provides new thiazolindinedione derivatives and new arylacetic acid derivatives. These compounds are useful for the treatment of cardiovascular diseases, certain endocrine diseases, certain inflammatory diseases, certain neoplastic (malignant) and non-malignant proliferative diseases, certain neuro-psychiatric disorders, certain viral diseases, and diseases associated with these viral infections as discussed herein.
    这项发明提供了新的噻唑烷二酮衍生物和新的芳基乙酸衍生物。这些化合物对治疗心血管疾病、某些内分泌疾病、某些炎症性疾病、某些恶性和非恶性增殖性疾病、某些神经精神障碍、某些病毒性疾病以及与这些病毒感染相关的疾病是有用的。
  • Design and Synthesis of the First Generation of Dithiolane Thiazolidinedione- and Phenylacetic Acid-Based PPARγ Agonists
    作者:Amar G. Chittiboyina、Meenakshi S. Venkatraman、Cassia S. Mizuno、Prashant V. Desai、Akshay Patny、Stephen C. Benson、Christopher I. Ho、Theodore W. Kurtz、Harrihar A. Pershadsingh、Mitchell A. Avery
    DOI:10.1021/jm0510880
    日期:2006.7.1
    A series of novel derivatives of potent antioxidant vitamin, alpha-lipoic acid, and related analogues were designed, synthesized, and evaluated for their PPAR gamma agonist activities. Compounds 9a and the water soluble analogue 11e were found to be potent PPAR gamma agonists. Compound 9a appeared to have a significant role in improving insulin sensitivity and reducing triglyceride levels in fa/fa rats as well as inhibited proliferation of a variety of normal and neoplastic cultured human cell types. These novel compounds may prove efficacious not only in the treatment of Type 2 diabetes, but also atherosclerosis, prevention of vascular restenosis, and inflammatory skin diseases.
查看更多